Ariadne Wealth Management, LP Bristol Myers Squibb CO Transaction History
Ariadne Wealth Management, LP
- $219 Billion
- Q4 2024
A detailed history of Ariadne Wealth Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 7,272 shares of BMY stock, worth $444,246. This represents 0.18% of its overall portfolio holdings.
Number of Shares
7,272
Previous 7,095
2.49%
Holding current value
$444,246
Previous $388 Million
4.03%
% of portfolio
0.18%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,761Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.69 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.87 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.81 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...